Skip to content
EntityQ7131441· pop 15· linked from 316 articles

panobinostat

Sign in to save

Also known as LBH589, Farydak®, LBH-589, LBH 589, (2E)-N-hydroxy-3-[4-({[2-(2-methyl-1H-indol-3-yl)ethyl]amino}methyl)phenyl]acrylamide

Panobinostat, sold under the brand name Farydak, is a medication used for the treatment of multiple myeloma. It is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor (pan-HDAC inhibitor).

In the Vinony graph

Vinony's link graph records 316 inbound references to panobinostat, and connects out to valproic acid, sodium phenylbutyrate and tiazofurin.

It is catalogued under topics including Cancer treatments, CYP2D6 inhibitors and Drugboxes which contain changes to verified fields.

Vinony links it to 14 Wikipedia language editions.

Research

1,263 papers

via PubMed

Wikidata facts

Mass
349.179
Show 5 more facts
chemical formula
C₂₁H₂₃N₃O₂
canonical SMILES
CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)C=CC(=O)NO
isomeric SMILES
CC1=C(C2=CC=CC=C2N1)CCNCC3=CC=C(C=C3)/C=C/C(=O)NO
World Health Organisation international non-proprietary name
panobinostat
Commons category
Panobinostat
Sources (5)

via Wikidata · CC0

~6 min read

Encyclopedic overview

9 sections
Contents
  • Medical uses
  • Contraindications
  • Side effects
  • Pharmacology
  • Mechanism of action
  • Pharmacokinetics
  • Clinical trials
  • Preclinical studies
  • References

{{Drugbox | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 455315413 | image = Panobinostat.svg | image_class = skin-invert-image | width = 275 | alt =

| pronounce = | tradename = Farydak | Drugs.com = | DailyMedID = Panobinostat | pregnancy_AU = | pregnancy_category = | routes_of_administration = By mouth | ATC_prefix = L01 | ATC_suffix = XH03 | ATC_supplemental =

Excerpted from Wikipedia’s “panobinostat” article, available under the CC BY-SA 4.0 licence.

Connections

Categories